Mometasone

Drug Profile

Mometasone

Alternative Names: Altosone; Asmanex Twisthaler; Ecotone; Ecural; Elica; Elocon; Fulmeta; Mometasone furoate monohydrate; Nasonex; Novasone; Rinelon; Rivelon; SCH 32088; Uniclar

Latest Information Update: 17 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Schering-Plough
  • Developer Merck & Co
  • Class Anti-inflammatories; Antiallergics; Antiasthmatics; Glucocorticoids; Pregnadienediols; Skin disorder therapies
  • Mechanism of Action Glucocorticoid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic rhinitis; Asthma; Nasal polyps; Perennial allergic rhinitis; Seasonal allergic rhinitis; Sinusitis; Skin disorders
  • No development reported Chronic obstructive pulmonary disease

Most Recent Events

  • 10 May 2018 Kyorin Pharmaceutical acquires distribution rights from MSD for mometasone for Allergic rhinitis in Japan
  • 28 Feb 2017 Merck has patent protection for mometasone (Asmanex®) in Europe and Japan (Merck Annual report 2016)
  • 15 Sep 2016 MSD and Kyorin agree to co-promote Nasonex® in Allergic rhinitis in Japan
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top